维普期刊资源整合服务平台（V6.5）

81篇 您的检索式：作者名="SCARPIGNATO C"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	The burden of constipation on quality of life:Results of a multinational survey显示文摘	Wald A Scarpignato C Kamm MA	2007	Aliment Pharmacol Ther2007，1526，2：	1
2	Reflux related symptoms in patients with normal oesophageal exposure acid显示文摘	Shi G Bruley des Varannes S Scarpignato C	1995	Gut1995，37，4：	1
3	Editorial:healing of refracto- ry reflux oesophagitis-an ongoing unmet clinical need 显示文摘	Hunt RH Yuan Y Scarpignato C	2014	Aliment Pharmacol Ther2014，40，8：	1
4	Somatostatin analogs for cancer treatment and diagnosis : an overview 显示文摘	SCARPIGNATO C PELOSINI I	2001	Chemotherapy2001，47，2：	1
5	‘Rescue' therapies for the management of Helicobacter pylori infection显示文摘	Di Mario F Cavallaro LG Scarpignato C	2006	Dig Dis2006，24，12：	1
6	Safe prescribing of non-steroidal anti-inflammatory drugs in patients with osteoarthritis-an expert consensus addressing benefits as well as gastrointestinaland cardiovascular risks显示文摘	Scarpignato C Lanas A Blandizzi C	2015	BMC Med2015，13，1：	1
7	Rifaximin,a poorly absorbed antibiotic:pharmacology and clinical potential显示文摘	Scarpignato C Pelosini I	2005	Chemotherapy2005，511，：	1
8	Poor effectiveness of proton pump inhibitors in non-erosive reflux disease: the truth in the end! 显示文摘	Scarpignato C	2012	Neurogastroenterol Motil2012，24，8：	1
9	Microbial flora in NSAID-induced intestinal damage:a role for antibioties?显示文摘	Lanaa A Scarpignato C	2006	Digestion2006，73，：	1
10	Proton pump in- hibitors in GORD an overview of their phamacology, effi- cacy and safety 显示文摘	Savarino V Di Mario F Scarpignato C	2009	Phamaol Res2009，59，3：	1
11	Microbial flora in NSAID-induced intestinal damage:a role for antibiotics?显示文摘	Lanas A Scarpignato C	2006	Digestion2006，73，1：	1
12	Nonsteroidal antiinflammatory drug-related injury to the gastrointestinal tract:clinical picture,pathogenesis,and prevention显示文摘	Scarpignato C Hunt RH		0，，3：	1
13	Proton pump inhibitors in GORD An overview of their pharmacology, efficaey and safety显示文摘	Savarino V Di Mario F Scarpignato C	2009	Pharmacol Res2009，59，：	1
14	Inhibition of acetylcholine induced intestinal motility by interleukin 1 beta in the rat显示文摘	Aubé AC Blottière HM Scarpignato C		0，，03：	1
15	Can Gangrenous Cholecystitis be Prevented?: A Plea Against a “Wait and See” Attitude显示文摘	S Contini D Corradi N Busi L Alessandri A Pezzarossa C Scarpignato	2004	Journal of Clinical Gastroenterology2004，，8：	1
16	Towards the ideal regimen for Helicobacter pylorie radication:the search continues显示文摘	Scarpignato C	2004	Digest Liver Dis2004，36，4：	1
17	The burden of constipation on quality of life:results of amuhinational survey 显示文摘	Wald A Scarpignato C Kamm MA	2007	Aliment Pharmacol Ther2007，26，2：	1
18	Commentary: towards an effective and safe treatment of small intestine bacterial overgrowth 显示文摘	Scarpignato C Gatta L	2013	Alimenta- ry Pharmacology and Therapeutics2013，38，1112：	1
19	The burden of constipation on quality of life:results of amultinational sur- vey 显示文摘	Wald A Scarpignato C Kamm MA	2007	Aliment Pharmacol Ther2007，26，2：	1
20	A multinational survey of prevalence and patterns of laxative use among adults with self-defined constipation 显示文摘	Wald A Scarpignato C Mueller-Lissner S	2008	Aliment Pharmacol Ther2008，28，7：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示